Loading insider details...
Beta
Latest Form 4 (Oct 19, 2026): Exercise/Conversion of 822 ARQT shares, $5.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Exercise/Conversion | 822 | $5.4K |
| Sep 17, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Exercise/Conversion | 822 | $5.4K |
| Aug 19, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Exercise/Conversion | 822 | $5.4K |
| Jul 17, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Exercise/Conversion | 822 | $5.4K |
| Jun 18, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Exercise/Conversion | 822 | $5.4K |
| Jun 10, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 5,778 | n/a |
| May 6, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 7,144 | $164.2K |
| Apr 3, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 10,000 | $238.8K |
| Mar 4, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 10,000 | $256.5K |
| Feb 5, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 10,000 | $250.5K |